X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CMRX

Closed

Chimerix Inc

8.54
0.00 (0.00%)
Last Update: 21 Apr 2025 16:30:00
Yesterday: 8.54
Day's Range: 8.54 - 8.54
Send
When Written:
 
1.26
Chimerix Inc. is a biopharmaceutical company that focuses on developing antiviral therapies to treat life-threatening diseases. The company's lead product, brincidofovir, is an antiviral drug that is being developed to treat cytomegalovirus (CMV) infections in transplant patients. Chimerix is also developing therapies for other viral infections, including adenovirus, BK virus, and smallpox. The company was founded in 2000 and is headquartered in Durham, North Carolina. Chimerix is publicly traded on the NASDAQ stock exchange under the ticker symbol CMRX.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X